VTN and early-onset autosomal dominant Alzheimer disease: One of nine neurological controls (an Alzheimer’s disease case) showed no complement staining, but for the other neurological controls, staining for most complement proteins was seen in a similar number of cases to that in MS; the exception was C1q staining which was significantly higher in MS tissue (Figure 2).